<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220715055472N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-07-18</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>To compare the effects of exergame and exercises with exercises only on functional activities in newly fitted patients with unilateral trans tibial amputation</public_title>
      <acronym></acronym>
      <scientific_title>To compare the effects of exergame and exercises with exercises only on functional activities in newly fitted patients with unilateral trans tibial amputation</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-10-01</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>22</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/64769</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: simple randomization in which 22 cards collected inside a plastic container. card with number one represent experimental group and card number two represent control group, Blinding description: The assessor was blinded to the type of group.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Exergame and exercises for patients with trans tibial amputation.</hc_freetext>
      <i_freetext>Intervention 1: Experimental group: The patients did home strengthening exercise and gait training exercises to improve their strength, balance, gait pattern, and coordination under the supervision of the first author. After that, the patients played the six games using XBOX Kinect, 3 times per week for 4 weeks. Intervention 2: Control group: The patients in the control group received home strengthening exercise for the global muscles (quadriceps, hamstring, hip and core muscles) and gait training exercises only under the supervision of the first author. The protocol was 3 sessions per week for four weeks in total.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
all collected deidentified IPD, IPD collected for the primary outcome measure only

When:
starting 6 months after publication

To whom:
For academic and clinician physiotherapist and those who are working in the field of rehabilitation.

Conditions:
no specific criteria

Where to obtain:
first author and the journal

How to obtain:
email the author, or the journal

Comments:
no comments</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohammed Abdul Hussein Jabbar Al Sawaedi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>NO.77 south west of new Baghdad</address>
        <city>Baghdad</city>
        <country1>Iraq</country1>
        <zip>100001</zip>
        <telephone>+964 771 109 0342</telephone>
        <email>mohamedphysiotherapy@yahoo.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mohammed Abdul Hussein Jabbar Al Sawaedi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>NO.77 south west of New Baghdad</address>
        <city>Baghdad</city>
        <country1>Iraq</country1>
        <zip>100001</zip>
        <telephone>+964 771 109 0342</telephone>
        <email>mohamedphysiotherapy@yahoo.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iraq</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Newly fitted patients with unilateral Trans-tibial amputation
Age ranged from 30 to 65 years
Be cognitively able to engage in the program (receive a score on the Arabic version of the Modified Mini-Mental Status Exam score of &gt;23)
Participants should not have any medical conditions (e.g., Congestive heart failure, Neurological disorder) that limit exercise participation.</inclusion_criteria>
      <agemin>30 years</agemin>
      <agemax>65 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria>Unable to give informed consent
Previous experience of using the XBOX Kinect™
Major cardiopulmonary problems.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Experimental group: The patients did home strengthening exercise and gait training exercises to improve their strength, balance, gait pattern, and coordination under the supervision of the first author. After that, the patients played the six games using XBOX Kinect, 3 times per week for 4 weeks.</i_keyword>
      <i_keyword>Control group: The patients in the control group received home strengthening exercise for the global muscles (quadriceps, hamstring, hip and core muscles) and gait training exercises only under the supervision of the first author. The protocol was 3 sessions per week for four weeks in total.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Distance of walking: 2MWT was administered to check the distance of walking in the meter before and after the intervention. The test was implemented on a walking path that is free from obstacles (including other people) and 50 feet in length as available. The measuring wheel  was used to measure the exact distance be covered by the patient during the test. The physiotherapist holds the walking wheel and walk behind the patient to calculate the distance. The patient walked for 2 minutes and the distance was calculated automatically by measuring the wheel. The assistive device could be used and was documented from test to test. The time starts upon “Go” and stop timing at 2 minutes. The patient will be instructed as follows “Cover as much ground as possible over 2 minutes. Walk continuously if possible, but do not be concerned if you need to slow down or stop to rest. The goal is to feel at the end of the test that more ground could not have been covered in the 2 minutes.” There are different pathways that can be used in the 2MWT. in this study,  “Out and Back” pathway  was chosen. Timepoint: At baseline, after two weeks and after four weeks of the intervention. Method of measurement: 2 Minutes Walking test (2MWT).</prim_outcome>
      <prim_outcome>The speed of walking: The TUG test was used to assess the speed of walking before and after the intervention. Measuring tape, chair with armrest, tape to mark the ground, and stopwatch was used in this test.  A 3-meter (or 9 ft, 10 in) walkway was measured by the measuring tape. On one end,  a chair was placed facing down the walkway with the front legs as the start point of the 3-meter distance. On the other end, a piece of tape (or cone) was placed to serve as a marker. The patient sat on a chair with their back against the back rest  preparing for the test. The patient was instructed as following; “When I say ‘go’, stand up and walk to the marker in front of you. Turn around once you get to the marker and return to your chair and sit. Make sure that you walk quickly, but safely.” the time that was required by the patient to complete the test, was measured. The stopwatch starts by saying, “Go” and stopped once the patient’s bottom contacts the chair. Usage of an assistive device was allowed and was documented consistently at each additional assessment. The patient was allowed one practice trial prior to the timed performance. The Clinical Metrics and Instructions Sheet includes updated tables with values for tested populations  was printed and laminated and was used as a reference during the test. Timepoint: At baseline, after two weeks and after four weeks of the intervention. Method of measurement: Time up and Go test (TUG).</prim_outcome>
      <prim_outcome>Functional activities: The functional activities of the patient  were measured using the Amputee Mobility Predictor with Prosthesis Test (AMPPRO) as described by Gailey . The test consists of 42 scores. The test was designed to assess the functional ambulation in patients with lower limb amputation. The AMP can be administered with a prosthesis  (AMPPRO) or without a prosthesis (AMPPRE). In this study, the participants used their prosthesis for the test. The AMPPRO takes approximately 15 minutes to apply. AMP Scores have been correlated with the functional Medicare classification system of 0 - 4 . Mean AMP scores for each K level are: K1 0-1 (25), K2 2 (34.6), K3 3 (40.5), K4 4 (44.7). The AMPPRO is reliable and valid for patients with transtibial amputations with excellent interrater and interrater reliability and with intraclass coefficient (ICC) scores ranging from 0.96 to 0.99. Timepoint: At baseline, after two weeks and after four weeks of the intervention. Method of measurement: Amputee Mobility Predictor with Prosthesis test (AMPPro).</prim_outcome>
      <prim_outcome>Energy expenditure: The physiological Cost Index (PCI) was used to measure the energy expenditure. PCI is a reliable test to track the changes of metabolic energy expenditure.  The test  was administered during the 2MWT as follows: 1.The patient sits quietly for 2 minutes until the heart rate reaches a steady state.2. The walking speed was measured in meters per minute. The participants walked on a level surface at their preferred pace. 3.The working heart rate was measured using Polar H7 for measuring heart rate. 4.After finishing the 2MWT, the heart rate was subtracted and divided by walking speed to obtain the PCI in beat/meter (see the equation below). 5.The participants was instructed to avoid taking any tobacco, coffee/tea or a big meal at least 2 h  before the PCI-test. Timepoint: At baseline, after two weeks and after four weeks of the intervention. Method of measurement: Physiological Cost Index test (PCI).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-09-26</approval_date>
        <contact_name>Ethical Committee of Tehran University of Medical Sciences</contact_name>
        <contact_address>Central building, Ghods street, Keshavarz Blvd, Tehran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
